| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 86, 1810-1818, Copyright © 1992 by American Heart Association
S Neubauer, T Krahe, R Schindler, M Horn, H Hillenbrand, C Entzeroth, H Mader, EP Kromer, GA Riegger and K Lackner
BACKGROUND. The purpose of this work was to further define the value of
cardiac 31P magnetic resonance (MR) spectroscopy for patients with coronary
artery disease and dilated cardiomyopathy. METHODS AND RESULTS.
Blood-corrected and T1-corrected 31P MR spectra of anteroseptal myocardium
were obtained at rest using image-selected in vivo spectroscopy
localization, a selected volume of 85 +/- 12 cm3, and a field strength of
1.5 T. Nineteen volunteers had a creatine phosphate (CP)/ATP ratio of 1.95
+/- 0.45 (mean +/- SD) and a PDE/ATP ratio of 1.06 +/- 0.53; in four
patients with left anterior descending coronary artery (LAD) stenosis, six
patients with chronic anterior wall infarction, and four patients with
chronic posterior wall infarction, CP/ATP and phosphodiester (PDE)/ATP
ratios did not differ from those in volunteers. Twenty-five measurements of
19 patients with dilated cardiomyopathy yielded a CP/ATP of 1.78 +/- 0.51
and a PDE/ATP of 0.98 +/- 0.56 (p = NS versus volunteers). When these
patients were grouped according to the severity of heart failure, however,
CP/ATP was 1.94 +/- 0.43 in mild (p = NS versus volunteers) and 1.44 +/-
0.52 in severe DCM (p < 0.05), respectively. No correlation was found
between CP/ATP and left ventricular ejection fraction or fractional
shortening, but correlation of CP/ATP with the New York Heart Association
(NYHA) class was significant (r = 0.60, p < 0.005). Six patients with
dilated cardiomyopathy were studied repeatedly before and after 12 +/- 6
weeks of drug treatment leading to clinical recompensation with improvement
of the NYHA status by 0.8 +/- 0.3 classes. Concomitantly, CP/ATP increased
from 1.51 +/- 0.32 to 2.15 +/- 0.27 (p < 0.01), whereas PDE/ATP did not
change significantly. CONCLUSIONS. Cardiac high-energy phosphate metabolism
at rest is normal in LAD stenosis and chronic myocardial infarction in the
absence of heart failure. The CP/ATP ratio has low specificity for the
diagnosis of dilated cardiomyopathy. However, CP/ATP correlated with the
clinical severity of heart failure and may improve during clinical
recompensation.
ARTICLES
31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure
Department of Medicine, Wurzburg University, FRG.
This article has been cited by other articles:
 |
|
 |
|
  M. Beer, D. Wagner, J. Myers, J. Sandstede, H. Kostler, D. Hahn, S. Neubauer, and P. Dubach Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1883 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Eisen Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1892 - 1895. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Neubauer The Failing Heart -- An Engine Out of Fuel N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151. [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium Circulation, September 12, 2006; 114(11): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Murray, C. A. Lygate, M. A. Cole, C. A. Carr, G. K. Radda, S. Neubauer, and K. Clarke Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart Cardiovasc Res, July 1, 2006; 71(1): 149 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Chen and O. Ogut Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin Am J Physiol Cell Physiol, March 1, 2006; 290(3): C719 - C727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Naumova, V. P. Chacko, R. Ouwerkerk, L. Stull, E. Marban, and R. G. Weiss Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H837 - H843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wallis, C. A. Lygate, A. Fischer, M. ten Hove, J. E. Schneider, L. Sebag-Montefiore, D. Dawson, K. Hulbert, W. Zhang, M. H. Zhang, et al. Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure: Insights From Creatine Transporter-Overexpressing Transgenic Mice Circulation, November 15, 2005; 112(20): 3131 - 3139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Caus, F. Kober, A. Mouly-Bandini, A. Riberi, D. R. Metras, P. J. Cozzone, and M. Bernard 31P MRS of heart grafts provides metabolic markers of early dysfunction Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 576 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Weiss, G. Gerstenblith, and P. A. Bottomley ATP flux through creatine kinase in the normal, stressed, and failing human heart PNAS, January 18, 2005; 102(3): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF]
|
|
|
|
|
|
J. A.C. Lima and M. Y. Desai Cardiovascular magnetic resonance imaging: Current and emerging applications J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1164 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nakae, K. Mitsunami, T. Omura, T. Yabe, T. Tsutamoto, S. Matsuo, M. Takahashi, S. Morikawa, T. Inubushi, Y. Nakamura, et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1587 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ogut and F. V. Brozovich Creatine Phosphate Consumption and the Actomyosin Crossbridge Cycle in Cardiac Muscles Circ. Res., July 11, 2003; 93(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Cha, P. P. Dzeja, W. K. Shen, A. Jahangir, C. Y. T. Hart, A. Terzic, and M. M. Redfield Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1313 - H1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.A. Poole-Wilson Who are the enemies? Lack of oxygen Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G15 - G19. [Abstract] [PDF]
|
|
|
|
|
|
M. Beer, T. Seyfarth, J.o. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Poole-Wilson Treatment of Acute Heart Failure: Out With the Old, In With the New JAMA, March 27, 2002; 287(12): 1578 - 1580. [Full Text] [PDF]
|
|
|
|
|
|
M. Horn, H. Remkes, H. Stromer, C. Dienesch, and S. Neubauer Chronic Phosphocreatine Depletion by the Creatine Analogue {beta}-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction Circulation, October 9, 2001; 104(15): 1844 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.M. Bengel, B. Permanetter, M. Ungerer, S.G. Nekolla, and M. Schwaiger Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography Eur. Heart J., September 1, 2001; 22(17): 1594 - 1600. [Abstract] [PDF]
|
|
|
|
 |
|
 P. A. Bottomley and R. G. Weiss Noninvasive Localized MR Quantification of Creatine Kinase Metabolites in Normal and Infarcted Canine Myocardium Radiology, May 1, 2001; 219(2): 411 - 418. [Abstract] [Full Text]
|
|
|
|
|
|
V. P. Chacko, F. Aresta, S. M. Chacko, and R. G. Weiss MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2218 - H2224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bollano, E. Omerovic, M. Bohlooly-Y, V. Kujacic, B. Madhu, J. Tornell, O. Isaksson, B. Soussi, W. Schulze, M. L. X. Fu, et al. Impairment of Cardiac Function and Bioenergetics in Adult Transgenic Mice Overexpressing the Bovine Growth Hormone Gene Endocrinology, June 1, 2000; 141(6): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Buchthal, J. A. den Hollander, C. N. B. Merz, W. J. Rogers, C. J. Pepine, N. Reichek, B. L. Sharaf, S. Reis, S. F. Kelsey, and G. M. Pohost Abnormal Myocardial Phosphorus-31 Nuclear Magnetic Resonance Spectroscopy in Women with Chest Pain but Normal Coronary Angiograms N. Engl. J. Med., March 23, 2000; 342(12): 829 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hugel, M. Horn, M. de Groot, H. Remkes, C. Dienesch, K. Hu, G. Ertl, and S. Neubauer Effects of ACE inhibition and beta -receptor blockade on energy metabolism in rats postmyocardial infarction Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2167 - H2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shen, K. Asai, M. Uechi, M. A. Mathier, R. P. Shannon, S. F. Vatner, and J. S. Ingwall Progressive Loss of Myocardial ATP Due to a Loss of Total Purines During the Development of Heart Failure in Dogs : A Compensatory Role for the Parallel Loss of Creatine Circulation, November 16, 1999; 100(20): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Horn, H. Remkes, C. Dienesch, K. Hu, G. Ertl, and S. Neubauer Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction Cardiovasc Res, July 1, 1999; 43(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B M Pluim, C A Swenne, A H Zwinderman, A C Maan, A van der Laarse, J Doornbos, and E E Van der Wall Correlation of heart rate variability with cardiac functional and metabolic variables in cyclists with training induced left ventricular hypertrophy Heart, June 1, 1999; 81(6): 612 - 617. [Abstract] [Full Text]
|
|
|
|
|
|
W.-I. Jung, L. Sieverding, J. Breuer, T. Hoess, S. Widmaier, O. Schmidt, M. Bunse, F. van Erckelens, J. Apitz, O. Lutz, et al. 31P NMR Spectroscopy Detects Metabolic Abnormalities in Asymptomatic Patients With Hypertrophic Cardiomyopathy Circulation, June 30, 1998; 97(25): 2536 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Conway, P. A. Bottomley, R. Ouwerkerk, G. K. Radda, and B. Rajagopalan Mitral Regurgitation : Impaired Systolic Function, Eccentric Hypertrophy, and Increased Severity Are Linked to Lower Phosphocreatine/ATP Ratios in Humans Circulation, May 5, 1998; 97(17): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Neubauer, M. Horn, M. Cramer, K. Harre, J. B. Newell, W. Peters, T. Pabst, G. Ertl, D. Hahn, J. S. Ingwall, et al. Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy Circulation, October 7, 1997; 96(7): 2190 - 2196. [Abstract] [Full Text]
|
|
|
|
|
|
L. Nascimben, J. S. Ingwall, P. Pauletto, J. Friedrich, J. K. Gwathmey, V. Saks, A. C. Pessina, and P.D. Allen Creatine Kinase System in Failing and Nonfailing Human Myocardium Circulation, October 15, 1996; 94(8): 1894 - 1901. [Abstract] [Full Text]
|
|
|
|
|
|
B. Andersson, K. Caidahl, A. di Lenarda, S. E. Warren, F. Goss, A. Waldenstrom, S. Persson, I. Wallentin, A. Hjalmarson, and F. Waagstein Changes in Early and Late Diastolic Filling Patterns Induced by Long-term Adrenergic ß-Blockade in Patients With Idiopathic Dilated Cardiomyopathy Circulation, August 15, 1996; 94(4): 673 - 682. [Abstract] [Full Text]
|
|
|
|
|
|
R. Liao, L. Nascimben, J. Friedrich, J. K. Gwathmey, and J. S. Ingwall Decreased Energy Reserve in an Animal Model of Dilated Cardiomyopathy : Relationship to Contractile Performance Circ. Res., May 1, 1996; 78(5): 893 - 902. [Abstract] [Full Text]
|
|
|
|
|
|
J. Friedrich, C. S. Apstein, and J. S. Ingwall 31P Nuclear Magnetic Resonance Spectroscopic Imaging of Regions of Remodeled Myocardium in the Infarcted Rat Heart Circulation, December 15, 1995; 92(12): 3527 - 3538. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yabe, K. Mitsunami, T. Inubushi, and M. Kinoshita Quantitative Measurements of Cardiac Phosphorus Metabolites in Coronary Artery Disease by 31P Magnetic Resonance Spectroscopy Circulation, July 1, 1995; 92(1): 15 - 23. [Abstract] [Full Text]
|
|